Duearity AB Cash Flow Conversion Efficiency
Duearity AB cash flow conversion efficiency. Based on the latest financial reports, Duearity AB (DEAR) has a cash flow conversion efficiency ratio of 0.036x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-416.00K ≈ $-44.77K USD) by net assets (Skr-11.54 Million ≈ $-1.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Duearity AB (2020–2023)
Cash flow conversion efficiency of Duearity AB from 2020 to 2023. This chart illustrates how Duearity AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Duearity AB for real-time trading data and today's change.
Duearity AB Cash Flow Conversion Ratio Explained
Duearity AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Duearity AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Duearity AB ranked by their cash flow conversion efficiency. Also see Duearity AB market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eden Research plc
LSE:EDEN
|
-0.048x |
|
Krakchemia SA
WAR:KCH
|
0.004x |
|
PUNCH PUNK S.A. ZY-10
F:6K7
|
N/A |
|
Southstone Minerals Ltd
V:SML
|
-0.898x |
|
Tortilla Mexican Grill PLC
LSE:MEX
|
-0.810x |
|
Challenger Energy Group PLC
LSE:CEG
|
-0.008x |
|
Blaize Holdings, Inc. Warrants
NASDAQ:BZAIW
|
-0.507x |
|
Profusa, Inc. Common Stock
NASDAQ:PFSA
|
0.091x |
Annual Cash Flow Conversion Efficiency for Duearity AB (2020–2023)
The table below shows the annual cash flow conversion efficiency of Duearity AB from 2020 to 2023. Review Duearity AB financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | Skr-2.39 Million ≈ $-256.77K |
Skr-24.36 Million ≈ $-2.62 Million |
10.207x | +404.16% |
| 2022-12-31 | Skr6.06 Million ≈ $652.48K |
Skr-20.35 Million ≈ $-2.19 Million |
-3.356x | -174.66% |
| 2021-12-31 | Skr11.04 Million ≈ $1.19 Million |
Skr-13.49 Million ≈ $-1.45 Million |
-1.222x | -331.51% |
| 2020-12-31 | Skr3.79 Million ≈ $408.19K |
Skr-1.07 Million ≈ $-115.58K |
-0.283x | -- |
About Duearity AB
Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help pe… Read more